These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 32578507

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
    Nagamine E, Hirayama K, Matsuda K, Okamoto M, Ohmachi T, Uchida K, Kadosawa T, Taniyama H.
    Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
    Smedley RC, Lamoureux J, Sledge DG, Kiupel M.
    Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A.
    Res Vet Sci; 2002 Aug 15; 73(1):45-51. PubMed ID: 12208106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Canine melanoma diagnosis: RACK1 as a potential biological marker.
    Campagne C, Julé S, Alleaume C, Bernex F, Ezagal J, Château-Joubert S, Estrada M, Aubin-Houzelstein G, Panthier JJ, Egidy G.
    Vet Pathol; 2013 Nov 15; 50(6):1083-90. PubMed ID: 23735618
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL, Veloso ES, Gonçalves INN, Costa RF, Rodrigues MA, Cassali GD, Del Puerto HL, Pang LY, Argyle DJ, Ferreira E.
    Vet Comp Oncol; 2020 Dec 15; 18(4):727-738. PubMed ID: 32323423
    [Abstract] [Full Text] [Related]

  • 19. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
    Pires I, Garcia A, Prada J, Queiroga FL.
    J Comp Pathol; 2010 Dec 15; 143(2-3):142-9. PubMed ID: 20207364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.